CN103816493B - A kind of Chinese medicine composition treating instability of kidney QI - Google Patents

A kind of Chinese medicine composition treating instability of kidney QI Download PDF

Info

Publication number
CN103816493B
CN103816493B CN201410107019.6A CN201410107019A CN103816493B CN 103816493 B CN103816493 B CN 103816493B CN 201410107019 A CN201410107019 A CN 201410107019A CN 103816493 B CN103816493 B CN 103816493B
Authority
CN
China
Prior art keywords
parts
rhizoma
kidney
chinese medicine
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410107019.6A
Other languages
Chinese (zh)
Other versions
CN103816493A (en
Inventor
刘春锋
王建蓉
邹积宝
Original Assignee
刘春锋
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 刘春锋 filed Critical 刘春锋
Priority to CN201410107019.6A priority Critical patent/CN103816493B/en
Publication of CN103816493A publication Critical patent/CN103816493A/en
Application granted granted Critical
Publication of CN103816493B publication Critical patent/CN103816493B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to a kind of Chinese medicine composition treating instability of kidney QI, its raw material of Chinese medicine and weight is: the Rhizoma Atractylodis Macrocephalae 10 30 parts, Rhizoma Dioscoreae 5 25 parts, 5 20 parts of Rhizoma Curcumae Longae, Pericarpium Citri Reticulatae 5 25 parts, Radix Ginseng 5 20 parts, Radix Angelicae Sinensis 5 25 parts, Rhizoma Coptidis 5 20 parts, Radix Codonopsis 5 25 parts, Semen Alpiniae Katsumadai 5 20 parts, Fructus Rubi 5 25 parts, Fructus Amomi 5 20 parts, Fructus Rosae Laevigatae 5 25 parts, Rhizoma Chuanxiong 5 20 parts, Semen Euryales 5 25 parts, Radix Salviae Miltiorrhizae 10 40 parts, Rhizoma Cyperi 5 25 parts, Bi 10 30 parts, Poria 5 25 parts, 5 15 parts of Radix Glycyrrhizae.The Chinese medicine composition of the present invention have tonify Qi of the kidney, controlling nocturnal emission with astringent drugs reducing urination, multiple arteries and veins are admittedly de-, effect of nourshing blood and promoting blood circulation, its treatment instability of kidney QI is evident in efficacy, reliable effect.

Description

A kind of Chinese medicine composition treating instability of kidney QI
Technical field
The present invention relates to the pharmaceutical product not determining structure of a kind of traditional herbal medicines, a kind of Chinese medicine composition treating instability of kidney QI.
Background technology
Instability of kidney QI, also known as instability of kidney-QI, refers to kidney qi virtual loss, the disease caused by astringency inducing malfunction.Due to deficiency of kidney-QI, dysfunction of the kidney in storing essence, rush not solid, and various symptom occurs.Clinical manifestation: soreness of the waist and knees, spiritlessness and weakness, tinnitus becomes deaf, frequent micturition and clear, night, more so or dribble of urine was not to the utmost, or the enuresis, or urinary incontinence.Man's spermatorrhea, premature ejaculation;Not to the utmost, or leukorrhagia is the dilutest and many for woman's menostaxis, or the easy edge of fetal movement.At present, the medicine that market is treated instability of kidney QI is varied, but there is the length course for the treatment of, curative effect is paid no attention to and is thought of the deficiency that side effect is big.
Motherland's medical science is thought, instability of kidney QI is many because year is high or natural endowment is not enough, or prolonged illness, chamber strain and cause in kidney caused by vigour virtual loss.
According to theory of Chinese medical science, for the pathogeny of instability of kidney QI, employing is tonified Qi of the kidney, the method for the treatment of of controlling nocturnal emission with astringent drugs reducing urination, carries out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome the medicine treating instability of kidney QI in prior art to there is the length course for the treatment of, curative effect pay no attention to and think of the deficiency that side effect is big, the present invention provides a kind of and prepares simplicity, low cost, evident in efficacy, the Chinese medicine composition for the treatment of instability of kidney QI that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition treating instability of kidney QI, it is characterised in that: its raw material of Chinese medicine and weight be: Rhizoma Atractylodis Macrocephalae 10-30 part, Rhizoma Dioscoreae 5-25 part, Rhizoma Curcumae Longae 5-20 part, Pericarpium Citri Reticulatae 5-25 part, Radix Ginseng 5-20 part, Radix Angelicae Sinensis 5-25 part, Rhizoma Coptidis 5-20 part, Radix Codonopsis 5-25 part, Semen Alpiniae Katsumadai 5-20 part, Fructus Rubi 5-25 part, Fructus Amomi 5-20 part, Fructus Rosae Laevigatae 5-25 part, Rhizoma Chuanxiong 5-20 part, Semen Euryales 5-25 part, Radix Salviae Miltiorrhizae 10-40 part, Rhizoma Cyperi 5-25 part, Bi 10-30 part, Poria 5-25 part, Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition treating instability of kidney QI, it is characterised in that: its raw material of Chinese medicine and weight be: the Rhizoma Atractylodis Macrocephalae 20 parts, Rhizoma Dioscoreae 15 parts, 10 parts of Rhizoma Curcumae Longae, Pericarpium Citri Reticulatae 15 parts, Radix Ginseng 10 parts, Radix Angelicae Sinensis 15 parts, Rhizoma Coptidis 10 parts, Radix Codonopsis 15 parts, Semen Alpiniae Katsumadai 10 parts, Fructus Rubi 15 parts, Fructus Amomi 10 parts, Fructus Rosae Laevigatae 15 parts, Rhizoma Chuanxiong 10 parts, Semen Euryales 15 parts, Radix Salviae Miltiorrhizae 25 parts, Rhizoma Cyperi 15 parts, Bi 20 parts, Poria 15 parts, 10 parts of Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: the Rhizoma Atractylodis Macrocephalae has effect that invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis are antiabortive;Rhizoma Dioscoreae have strengthening the spleen and tonifying the lung, stomach reinforcing the kidney invigorating, benefit of reinforcing the kidney essence, hearing-improing and eyesight improving, help the five internal organs, bone and muscle strengthening, long will to calm the nerves, effect of life lengthening;Rhizoma Curcumae Longae has effect of removing blood stasis circulation of qi promoting, inducing menstruation to relieve menalgia;Pericarpium Citri Reticulatae has diuretic, effect of drying dampness to eliminate phlegm in regulating qi-flowing for strengthening spleen, tune;Radix Ginseng has strongly invigorating primordial QI, multiple arteries and veins takes off admittedly, effect of invigorating the spleen to benefit the lung;Radix Angelicae Sinensis has replenishing and activating blood, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation;Rhizoma Coptidis has effect of heat clearing and damp drying, eliminating fire and detoxication;Radix Codonopsis has effect of invigorating the spleen and replenishing QI, strengthening spleen and tonifying lung;Semen Alpiniae Katsumadai has warming spleen and stomach for dispelling cold, promoting the circulation of QI to relieve pain, drying damp and strengthening spleen effect;Fructus Rubi has the liver and the kidney tonifying, controlling nocturnal emission with astringent drugs reducing urination, effect of supporing yang improving eyesight;Fructus Amomi has removing dampness appetizing, warming spleen and stopping diarrha, antiabortive effect of regulating the flow of vital energy;Fructus Rosae Laevigatae has effect of controlling nocturnal emission with astringent drugs reducing urination, relieving diarrhea with astringents;Rhizoma Chuanxiong has effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping;Semen Euryales has supplementing the kidney to control the nocturnal, tonifying spleen and stopping diarrhea, effect of damp eliminating leukorrhagia stopping;Radix Salviae Miltiorrhizae has promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, effect of nourishing blood to tranquillize the mind;Rhizoma Cyperi has liver-smoothing, qi-regulating, effect of resolving depression pain relieving;Bi has dampness removing and goes turbid, to dispel the wind blood stasis dispelling effect;Poria has benefiting vital QI for tranquillizing, invigorating the spleen and regulating the stomach, dispels damp and hot, effect of row water stopping leak;Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component through dialectical compatibility, helps using mutually assistant, play altogether tonify Qi of the kidney, controlling nocturnal emission with astringent drugs reducing urination, multiple arteries and veins are admittedly de-, effect of nourshing blood and promoting blood circulation, the treatment to instability of kidney QI reaches treating both the principal and secondary aspects of a disease.
The component of the present composition all uses natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, low cost.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug use the use that is decocted in water for oral dose.Verifying by clinic application, it is evident in efficacy reliably, mild in medicine property and, do not occur that toxic and side effects, effective percentage reach 92.2%, cure rate 68.9%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
A kind of Chinese medicine composition treating instability of kidney QI, its raw material of Chinese medicine and weight proportion be: Rhizoma Atractylodis Macrocephalae 20g, Rhizoma Dioscoreae 15g, Rhizoma Curcumae Longae 10g, Pericarpium Citri Reticulatae 15g, Radix Ginseng 10g, Radix Angelicae Sinensis 15g, Rhizoma Coptidis 10g, Radix Codonopsis 15g, Semen Alpiniae Katsumadai 10g, Fructus Rubi 15g, Fructus Amomi 10g, Fructus Rosae Laevigatae 15g, Rhizoma Chuanxiong 10g, Semen Euryales 15g, Radix Salviae Miltiorrhizae 25g, Rhizoma Cyperi 15g, Bi 20g, Poria 15g, Radix Glycyrrhizae 10g.
Embodiment 2
A kind of Chinese medicine composition treating instability of kidney QI, its raw material of Chinese medicine and weight proportion be: Rhizoma Atractylodis Macrocephalae 15g, Rhizoma Dioscoreae 25g, Rhizoma Curcumae Longae 5g, Pericarpium Citri Reticulatae 20g, Radix Ginseng 12g, Radix Angelicae Sinensis 25g, Rhizoma Coptidis 5g, Radix Codonopsis 25g, Semen Alpiniae Katsumadai 12g, Fructus Rubi 20g, Fructus Amomi 5g, Fructus Rosae Laevigatae 20g, Rhizoma Chuanxiong 12g, Semen Euryales 25g, Radix Salviae Miltiorrhizae 10g, Rhizoma Cyperi 20g, Bi 15g, Poria 25g, Radix Glycyrrhizae 12g.
Embodiment 3
A kind of Chinese medicine composition treating instability of kidney QI, its raw material of Chinese medicine and weight proportion be: Rhizoma Atractylodis Macrocephalae 25g, Rhizoma Dioscoreae 10g, Rhizoma Curcumae Longae 15g, Pericarpium Citri Reticulatae 25g, Radix Ginseng 5g, Radix Angelicae Sinensis 20g, Rhizoma Coptidis 12g, Radix Codonopsis 20g, Semen Alpiniae Katsumadai 5g, Fructus Rubi 10g, Fructus Amomi 20g, Fructus Rosae Laevigatae 5g, Rhizoma Chuanxiong 15g, Semen Euryales 10g, Radix Salviae Miltiorrhizae 30g, Rhizoma Cyperi 5g, Bi 25g, Poria 10g, Radix Glycyrrhizae 8g.
Embodiment 4
A kind of Chinese medicine composition treating instability of kidney QI, its raw material of Chinese medicine and weight proportion be: Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Dioscoreae 20g, Rhizoma Curcumae Longae 12g, Pericarpium Citri Reticulatae 5g, Radix Ginseng 15g, Radix Angelicae Sinensis 10g, Rhizoma Coptidis 15g, Radix Codonopsis 5g, Semen Alpiniae Katsumadai 20g, Fructus Rubi 5g, Fructus Amomi 15g, Fructus Rosae Laevigatae 10g, Rhizoma Chuanxiong 20g, Semen Euryales 5g, Radix Salviae Miltiorrhizae 10g, Rhizoma Cyperi 25g, Bi 10g, Poria 20g, Radix Glycyrrhizae 5g.
Embodiment 5
A kind of Chinese medicine composition treating instability of kidney QI, its raw material of Chinese medicine and weight proportion be: Rhizoma Atractylodis Macrocephalae 30g, Rhizoma Dioscoreae 5g, Rhizoma Curcumae Longae 20g, Pericarpium Citri Reticulatae 10g, Radix Ginseng 20g, Radix Angelicae Sinensis 5g, Rhizoma Coptidis 20g, Radix Codonopsis 10g, Semen Alpiniae Katsumadai 15g, Fructus Rubi 25g, Fructus Amomi 12g, Fructus Rosae Laevigatae 25g, Rhizoma Chuanxiong 5g, Semen Euryales 20g, Radix Salviae Miltiorrhizae 40g, Rhizoma Cyperi 10g, Bi 30g, Poria 5g, Radix Glycyrrhizae 15g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: put in container by the raw material of Chinese medicine of prescription, adds cold water and covers powder, soak 15~20 minutes, added water no powder about 6 centimetres, carries out decocting for the first time, at a simmer before use intense fire to decoct, with slow fire boiling 20~30 minutes after boiling;Second time decocts, and added water no powder about 4 centimetres, decocts 15~20 minutes after water boiling.Decoct extracting juice twice, merge.
The present invention, with a kind of Chinese medicine composition treating instability of kidney QI given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 90 example, male 54 examples, female 36 example, age 20~55 years old.
Two, diagnosis basis:
The primary symptom showed according to its clinic, secondary disease, and combine tongue arteries and veins and make diagnosis:
1, primary symptom: frequent micturition number and clear, dribble of urine not to the utmost, the enuresis or incontinence, spermatorrhea premature ejaculation, easily slide by fetal movement;
2, secondary disease: pale complexion, spiritlessness and weakness, soreness of the waist and knees, auditory dysesthesia, spontaneous perspiration, clear and thin leucorrhea;
3, tongue arteries and veins: pale tongue with white fur, thready and weak pulse;
Possess 1 person in above-listed condition, assertive evidence can be diagnosed as.
Three, usage and dosage: during clinical practice, potion on the one, decocting twice extracting juice about 400ml, point morning, late twice decoction being taken warmly.It within six days, it is a course for the treatment of.
Four, criterion of therapeutical effect:
(1) recovery from illness: symptom and sign disappears, and does not recurs after disabling;
(2) effective: symptom is substantially alleviated, simultaneous phenomenon disappears substantially or big portion alleviates;
(3) effective: in high spirits and simultaneous phenomenon alleviates, but meet influence factor and then increase the weight of;
(4) invalid: all symptoms increase the weight of to tend to without alleviating or having.
Five, therapeutic effect: in this clinical observation case, take medicine 2-8 the course for the treatment of, 62 examples of fully recovering, follow up a case by regular visits to have no recurrence;Effective 12 examples, effective 9 examples, invalid 7 examples.Toxic and side effects is there is not during treatment.
Six, model case:
Case 1:
Bao, man, 36 years old.Frequent micturition number occurred and clear before two weeks, dribble of urine not to the utmost, the enuresis, spermatorrhea premature ejaculation, and with symptoms such as soreness of the waist and knees, auditory dysesthesia, spontaneous perspirations.Examine and see: pale tongue with white fur, thready and weak pulse.It is diagnosed as: instability of kidney QI.Taking 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, frequent micturition number of times significantly reduces, and remaining symptom is also eased;Continuing to take 2 courses for the treatment of, all diseases disappear, recovery from illness.Follow up a case by regular visits to after half a year without recurrence.
Case 2:
Poplar, female, 42 years old.Occurring frequent micturition before one and clear, night, more so not to the utmost, menostaxis not to the utmost, and had spiritlessness and weakness concurrently to dribble of urine, and tinnitus such as is become deaf the disease.Diagnosis: instability of kidney QI.Taking 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, total urination time reduces, and remaining symptom alleviates.Continue to take 2 courses for the treatment of, total urination time and menstruation recovery normal, other transference cures, recovery from illness.Follow up a case by regular visits to after 1 year without recurrence.

Claims (1)

1. the Chinese medicine composition treating instability of kidney QI, it is characterised in that: its raw material of Chinese medicine and weight proportion be: Rhizoma Atractylodis Macrocephalae 20g, Rhizoma Dioscoreae 15g, Rhizoma Curcumae Longae 10g, Pericarpium Citri Reticulatae 15g, Radix Ginseng 10g, Radix Angelicae Sinensis 15g, Rhizoma Coptidis 10g, Radix Codonopsis 15g, Semen Alpiniae Katsumadai 10g, Fructus Rubi 15g, Fructus Amomi 10g, Fructus Rosae Laevigatae 15g, Rhizoma Chuanxiong 10g, Semen Euryales 15g, Radix Salviae Miltiorrhizae 25g, Rhizoma Cyperi 15g, Bi 20g, Poria 15g, Radix Glycyrrhizae 10g.
CN201410107019.6A 2014-03-21 2014-03-21 A kind of Chinese medicine composition treating instability of kidney QI Expired - Fee Related CN103816493B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410107019.6A CN103816493B (en) 2014-03-21 2014-03-21 A kind of Chinese medicine composition treating instability of kidney QI

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410107019.6A CN103816493B (en) 2014-03-21 2014-03-21 A kind of Chinese medicine composition treating instability of kidney QI

Publications (2)

Publication Number Publication Date
CN103816493A CN103816493A (en) 2014-05-28
CN103816493B true CN103816493B (en) 2016-10-05

Family

ID=50751973

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410107019.6A Expired - Fee Related CN103816493B (en) 2014-03-21 2014-03-21 A kind of Chinese medicine composition treating instability of kidney QI

Country Status (1)

Country Link
CN (1) CN103816493B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107582978A (en) * 2017-10-19 2018-01-16 成都兴倍加生物科技有限责任公司 It is a kind of effectively to treat decoction medicine of the unconsolidation of the kidney-qi and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1363307A (en) * 2001-01-10 2002-08-14 杨孟君 Nano medicine 'Guiluningshen' and its preparing process
CN1480204A (en) * 2003-08-05 2004-03-10 刘顺礼 Preparation of Chinese herbal medicine for treating barrenness of women

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62198621A (en) * 1986-02-24 1987-09-02 Kanebo Ltd Carcinostatic assistant

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1363307A (en) * 2001-01-10 2002-08-14 杨孟君 Nano medicine 'Guiluningshen' and its preparing process
CN1480204A (en) * 2003-08-05 2004-03-10 刘顺礼 Preparation of Chinese herbal medicine for treating barrenness of women

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
环孢素A联合激素和中药治疗膜性肾病疗效分析;何志军等;《中国中西医结合肾病杂志》;20111031;第12卷(第10期);第900-901页,尤其是第900页左栏第4段、右栏第1段 *

Also Published As

Publication number Publication date
CN103816493A (en) 2014-05-28

Similar Documents

Publication Publication Date Title
CN103007191B (en) Chinese medicinal composition for treating jaundice
CN103341004B (en) Chinese medicine composition for treating delayed menstrual cycle
CN103028091B (en) Traditional Chinese medicine composition for treating damp heat of liver and gallbladder
CN103463587A (en) Traditional Chinese medicine composition for treating deficiency-cold in spleen and stomach
CN103705866A (en) Traditional Chinese medicine composition for treating hypomenorrhea
CN103386008A (en) Chinese medicine composition for treating endocrine dyscrasia
CN103223118B (en) Traditional Chinese medicine composition for treating facial paralysis
CN103007169B (en) Traditional Chinese medicine composition for treating insomnia
CN103550687B (en) A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency
CN104173565B (en) A kind of Chinese medicine composition treating menoxenia
CN103550661A (en) Chinese medicinal composition for treating stomach cold and stomachache
CN102949619A (en) Traditional Chinese medicine composition for treating colitis
CN103394030B (en) Traditional Chinese medicine composition for treating depressed liver and deficient spleen
CN103816337A (en) Traditional Chinese medicinal composition for treating delayed menstrual cycle
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN105477619A (en) Traditional Chinese medicine composition for treating delayed menorrhea
CN103041301A (en) Traditional Chinese medicine composition for treating icterohepatitis
CN103816493B (en) A kind of Chinese medicine composition treating instability of kidney QI
CN103007213A (en) Chinese medicinal composition for treating arthralgia
CN103028089B (en) Traditional Chinese medicine composition for treating waist pains of middle-aged and old people
CN104173932A (en) Traditional Chinese medicine composition for treating cervical spondylosis
CN103816403A (en) Chinese medicinal composition for treating syndrome of deficiency of liver blood
CN103800881A (en) Traditional Chinese medicine composition for treating heart-spleen deficiency syndrome
CN103690925A (en) Traditional Chinese medicinal composition for treating amenorrhea
CN102416150B (en) Chinese medicinal composition for treating diarrhoea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20160906

Address after: 264300 Shandong city of Weihai province Rongcheng Chengshan Avenue East No. 101

Applicant after: Liu Chunfeng

Address before: 264300 Shandong city of Weihai province Rongcheng Chengshan Avenue East No. 101

Applicant before: Wang Jianrong

CB03 Change of inventor or designer information

Inventor after: Liu Chunfeng

Inventor after: Wang Jianrong

Inventor after: Zou Jibao

Inventor before: Wang Jianrong

Inventor before: Zou Jibao

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20161005

Termination date: 20170321